Ciesielski, W.; Kupryś-Lipińska, I.; Kumor-Kisielewska, A.; Grząsiak, O.; Borodacz, J.; Niedźwiecki, S.; Hogendorf, P.; Durczyński, A.; Strzelczyk, J.; Majos, A.
Peripheral Eosinophil Count May Be the Prognostic Factor for Overall Survival in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Surgical Treatment. Biomedicines 2024, 12, 2596.
https://doi.org/10.3390/biomedicines12112596
AMA Style
Ciesielski W, Kupryś-Lipińska I, Kumor-Kisielewska A, Grząsiak O, Borodacz J, Niedźwiecki S, Hogendorf P, Durczyński A, Strzelczyk J, Majos A.
Peripheral Eosinophil Count May Be the Prognostic Factor for Overall Survival in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Surgical Treatment. Biomedicines. 2024; 12(11):2596.
https://doi.org/10.3390/biomedicines12112596
Chicago/Turabian Style
Ciesielski, Wojciech, Izabela Kupryś-Lipińska, Anna Kumor-Kisielewska, Oliwia Grząsiak, Julia Borodacz, Sebastian Niedźwiecki, Piotr Hogendorf, Adam Durczyński, Janusz Strzelczyk, and Alicja Majos.
2024. "Peripheral Eosinophil Count May Be the Prognostic Factor for Overall Survival in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Surgical Treatment" Biomedicines 12, no. 11: 2596.
https://doi.org/10.3390/biomedicines12112596
APA Style
Ciesielski, W., Kupryś-Lipińska, I., Kumor-Kisielewska, A., Grząsiak, O., Borodacz, J., Niedźwiecki, S., Hogendorf, P., Durczyński, A., Strzelczyk, J., & Majos, A.
(2024). Peripheral Eosinophil Count May Be the Prognostic Factor for Overall Survival in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Surgical Treatment. Biomedicines, 12(11), 2596.
https://doi.org/10.3390/biomedicines12112596
